JOHN R. TUNHEIM, District Judge.
This is a breach of contract action that has been bifurcated at the parties' request. At the conclusion of the liability phase of the trial, the jury found that defendant Mayo Clinic ("Mayo") breached a Confidential Separation Agreement it had entered into with plaintiff Dr. Deepak Kademani. Before the Court is Mayo's motion for relief from judgment pursuant to Federal Rule of Civil Procedure 60(b). Mayo's motion is based on its belief that Kademani testified falsely during the liability phase of the trial. For the reasons below, Mayo has failed to establish grounds for relief from judgment and the Court will deny Mayo's motion.
Kademani, worked for Mayo as a surgeon but was placed on administrative leave during a peer review of his practice in 2007. (Kademani Trial Tr. 287, 348, June 26, 2012, Docket No. 339.) The peer review ended without adverse conclusions or discipline and Kademani and Mayo entered into a Confidential Separation Agreement where Kademani agreed to resign and both parties agreed to not "disclose any information concerning the disputes that arose between the parties." (Fourth Aff. of Adrianna H. Shannon, Ex. 4 & Ex. 5 at 1, 3, Oct. 23, 2012, Docket No. 436.)
Kademani subsequently received an offer of employment from Massachusetts General Hospital ("MGH"). (Kaban Trial Tr. 804:11-19, Sept. 17, 2012, Docket No. 378.) Before Kademani's appointment was finalized, a surgeon and professor from Mayo contacted MGH's Chief of Surgery and informed the Chief of Surgery that "I think you should do your homework" with regard to Kademani. (Fourth Shannon Aff., Ex. 9 (Dep. of Dr. Michael Sarr ("Sarr Dep.") 19:10-17).) Shortly thereafter, Dr. Leonard Kaban, who is in charge of hiring at MGH, informed Kademani that Kademani might not successfully complete the credentialing process and Kademani decided to withdraw his application. (Kaban Trial Tr. 838:10-25, Docket No. 378.)
Mayo argued extensively during the liability phase of trial that Kademani had failed to disclose information about his dispute with Mayo during the application process and that he lost his opportunity at MGH due to his lack of candor, not due to Mayo's breach of the Confidential Separation Agreement. (See, e.g., Fourth Shannon Aff., Ex. 13, (Bunde Opening Argument), at 159-61.) The present motion is based on Mayo's contention that Kademani lied about when, and to what extent, he disclosed information to MGH.
At his deposition, Dr. Kaban testified that Kademani did not disclose the peer review "upfront in the interview process," but that Kademani did confirm that the peer review had occurred "[a]t a subsequent time."
Kademani testified at trial that he told Dr. Kaban about the peer review at Mayo before MGH made an offer of employment. (Kademani Trial Tr. 415:15-22, Sept. 17, 2012, Docket No. 377.) Kademani's counsel reminded Kademani that his testimony regarding the timing of his disclosures appeared to be inconsistent with the testimony offered by Dr. Kaban and Kademani asserted his belief that Dr. Kaban's recollection was incorrect. (Id. 416:3-12.) Kademani had also been made aware of the potential inconsistency between his and Dr. Kaban's recollections at a deposition prior to trial. (See Fifth Waytz Decl., Ex. B (Dep. of Dr. Deepak Kademani) 278-79.) Kademani testified in greater depth at trial regarding the nature of his disclosures to MGH, particularly in response to cross-examination by Mayo's counsel. (See Kademani Trial Tr. 467, 475-76, Docket No. 377.)
During discovery for the damages phase, the parties deposed Dr. Kaban for a second time.
In addition to Dr. Kaban's second deposition, Mayo points to documentary evidence that it contends casts doubt on Kademani's testimony regarding his disclosures to MGH. For instance, on February 20, 2008, after having offered Kademani the position, Dr. Kaban wrote to MGH's director of credentialing and enthusiastically requested Kademani's appointment. (Id., Ex. E.) Mayo also notes that the first piece of documentary evidence demonstrating that Kademani disclosed his issues at Mayo to MGH is a letter Kademani forwarded to MGH on March 2, 2008. (Id., Ex. G.)
Federal Rule of Civil Procedure 60(b) allows a court to relieve a party from a final judgment for a number of reasons, including "newly discovered evidence that, with reasonable diligence, could not have been discovered in time to move for a new trial under Rule 59(b)" and "fraud . . ., misrepresentation, or misconduct by an opposing party." See Fed. R. Civ. P. 60(b)(2) & (3). Rule 60(b) allows for "'extraordinary relief which may be granted only upon an adequate showing of exceptional circumstances.'" U.S. Xpress Enterps., Inc. v. J.B. Hunt Transport, Inc., 320 F.3d 809, 815 (8
Mayo's central argument is that "Dr. Kaban's post-trial testimony, when considered in light of all the circumstantial evidence presented at trial, constitutes clear and convincing evidence that [Kademani] lied at trial." (Def.'s Memo. in Support at 13, Nov. 5, 2012, Docket No. 447.) Mayo contends that "[Kademani]'s perjury . . . constitutes grounds for relief under [Rule] 60(b)(2) as newly discovered evidence" and that there is also sufficient evidence to warrant relief under Rule 60(b)(3). (See id. at 13-15.) Neither argument is persuasive, and the Court will address them in turn.
To prevail under Rule 60(b)(2), which addresses newly discovered evidence, the moving party must demonstrate that: (1) the evidence was discovered after trial; (2) due diligence was exercised to discover the evidence; (3) the evidence is material; (4) the evidence is not merely cumulative or impeaching; and (5) the evidence is such that a new trial would probably produce a different result. Schwieger v. Farm Bureau Ins. Co. of Neb., 207 F.3d 480, 487 (8
First, there is no "newly discovered evidence." Whatever conflict exists between Dr. Kaban's testimony and Kademani's testimony existed at trial. Dr. Kaban's assertion at his second deposition that Kademani "lied" was a more explicit way to highlight the conflicts in the testimony, but nothing new was discovered by virtue of Dr. Kaban's assertion. Even if Dr. Kaban's assertion constituted "newly discovered evidence," the Court would deny Mayo's motion because any conflict between Kademani and Dr. Kaban's recollections was apparent prior to the liability phase of the trial and Mayo could have been more diligent in attempting to obtain additional discovery from Dr. Kaban prior to the liability phase. Further, because the jury already heard the competing testimony of Dr. Kaban and Kademani, Dr. Kaban's additional, explicit assertion that Kademani "lied" would likely have been immaterial. Finally, because any conflict was already before the jury, Dr. Kaban's assertion is merely impeaching.
Mayo's claim under Rule 60(b)(3) fares no better. To prevail under Rule 60(b)(3), the moving party must demonstrate by clear and convincing evidence that the opposing party's fraud, misrepresentation, or misconduct "prevented the movant from fully and fairly presenting its case." Atkinson v. Prudential Prop. Co., 43 F.3d 367, 372-73 (8
Mayo relies heavily on Rosebud Sioux Tribe, which is easily distinguishable from the present case. In Rosebud Sioux Tribe, the court granted relief from a civil judgment when a key witness later provided grand jury testimony that dramatically contradicted testimony he had given in a deposition prior to the civil trial. See 733 F.2d at 514-17 ("The grand jury testimony flatly contradicts the testimony [the witness] gave in two other proceedings. . . . [H]is inconsistent stories demonstrate that he is a liar and, as such, a witness whose testimony is to be discredited."). In that case, the later testimony constituted newly discovered evidence and also clear and convincing evidence of misconduct. In order for Rosebud Sioux Tribe to be analogous to the present case, Kademani himself would have needed to say "I lied" in a second deposition. The situation at hand is categorically different.
Mayo has neither presented newly discovered evidence warranting relief from judgment under Rule 60(b)(2), nor has it presented clear and convincing evidence of fraud, misrepresentation, or misconduct warranting relief from judgment under Rule 60(b)(3). Therefore, the Court will deny Mayo's motion for relief from judgment.
Based on the foregoing, and all the files, records, and proceedings herein,
Because the Court will deny Mayo's motion, it need not address Kademani's argument that relief under Rule 60(b) is not available after the first phase of a bifurcated trial.